Search research articles
Contact Us
Filters
Showing results (121-130 of 329) with videos related to
Page
of 33
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
April 7, 2021
Specific and non-specific binding of a tracer for the translocator-specific protein in schizophrenia: an [11C]-PBR28 blocking study
Tiago Reis Marques, Mattia Veronese, David R Owen, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
May 15, 2025
Effectiveness of clozapine augmentation with specific doses of other antipsychotics in schizophrenia: a meta-analysis from two nationwide cohorts
Jari Tiihonen, Antti Tanskanen, Ellenor Mittendorfer-Rutz, et al.
Brain, Behavior, and Immunity
|
May 22, 2019
The association of psychosocial risk factors for mental health with a brain marker altered by inflammation: A translocator protein (TSPO) PET imaging study
Tarik Dahoun, Marilia A Calcia, Mattia Veronese, et al.
Bjpsych Open
|
February 16, 2024
Immune response to vaccination in people with psychotic disorders relative to healthy controls: prospective study of SARS-CoV-2 vaccination
Oisín O'Brien, Atheeshaan Arumuham, Yuya Mizuno, et al.
Brain : a Journal of Neurology
|
March 7, 2026
Schizophrenia and disordered sensorimotor control: challenges, mechanisms and opportunities
Albert Joseph, Rick A Adams, Fiona Gaughran, et al.
Biological Psychiatry
|
July 30, 2013
Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function
Arsime Demjaha, Alice Egerton, Robin M Murray, et al.
CNS Drugs
|
August 17, 2022
Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
C U Correll, Ofer Agid, Benedicto Crespo-Facorro, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 24, 2024
Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, et al.
Biological Psychiatry
|
July 4, 2013
Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms
Michael A P Bloomfield, Celia J A Morgan, Alice Egerton, et al.
Psychopharmacology
|
July 26, 2012
Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug use
Tom P Freeman, Celia J A Morgan, Fiona Pepper, et al.
Page
of 33
Search research articles
Search
Showing results (121-130 of 329) with videos related to
Sort By:
Page
of 33
European Journal of Nuclear Medicine and Molecular Imaging
|
April 7, 2021
Specific and non-specific binding of a tracer for the translocator-specific protein in schizophrenia: an [11C]-PBR28 blocking study
Tiago Reis Marques, Mattia Veronese, David R Owen, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)
|
May 15, 2025
Effectiveness of clozapine augmentation with specific doses of other antipsychotics in schizophrenia: a meta-analysis from two nationwide cohorts
Jari Tiihonen, Antti Tanskanen, Ellenor Mittendorfer-Rutz, et al.
Brain, Behavior, and Immunity
|
May 22, 2019
The association of psychosocial risk factors for mental health with a brain marker altered by inflammation: A translocator protein (TSPO) PET imaging study
Tarik Dahoun, Marilia A Calcia, Mattia Veronese, et al.
Bjpsych Open
|
February 16, 2024
Immune response to vaccination in people with psychotic disorders relative to healthy controls: prospective study of SARS-CoV-2 vaccination
Oisín O'Brien, Atheeshaan Arumuham, Yuya Mizuno, et al.
Brain : a Journal of Neurology
|
March 7, 2026
Schizophrenia and disordered sensorimotor control: challenges, mechanisms and opportunities
Albert Joseph, Rick A Adams, Fiona Gaughran, et al.
Biological Psychiatry
|
July 30, 2013
Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function
Arsime Demjaha, Alice Egerton, Robin M Murray, et al.
CNS Drugs
|
August 17, 2022
Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
C U Correll, Ofer Agid, Benedicto Crespo-Facorro, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
April 24, 2024
Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
Ofer Agid, Benedicto Crespo-Facorro, Andrea de Bartolomeis, et al.
Biological Psychiatry
|
July 4, 2013
Dopaminergic function in cannabis users and its relationship to cannabis-induced psychotic symptoms
Michael A P Bloomfield, Celia J A Morgan, Alice Egerton, et al.
Psychopharmacology
|
July 26, 2012
Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug use
Tom P Freeman, Celia J A Morgan, Fiona Pepper, et al.
Page
of 33